Federal Trade Commission
FROM Richard Feinstein
Expiring Patents, Drug Prices and the Hazy Market for Generics Patents are about to expire on two of the world's best-selling prescription drugs. Prices for cholesterol-fighter Lipitor and the blood-thinner Plavix are likely to drop by 80 percent when they're replaced by generics. But that's not all. The drug industry will be faced with an unprecedented wave of expiring patents in the next few years. What will the expiration of patents on many other drugs mean for Big Pharma? How is the industry fighting back? Will consumers get the benefits they deserve?
The flight bumping heard around 'round the world Recent video of a passenger forcibly removed from a United Airlines plane is a worst-case example of what's happened since consolidation into just four US-based carriers. Management seems to be tone-deaf to a decline in service — and even abuse — of passengers.
After Syria strike a new Trump doctrine emerges The President who promised an end to entanglements in the Middle East and snuggled up to Vladimir Putin has now outraged Russia with surprise missile attacks on Syria. That's raised questions about who's running the White House? We hear a variety of answers.
Truth and Lies in Trumpland Donald Trump is using mis-information like no President has before him. It's an unprecedented challenge to the news media, and a potential threat to democracy. We hear how the "leader of all the people" is dividing Americans and confusing the rest of the world.
Does 'hire American' mean fire a foreigner? US companies are allowed to hire employees from other countries with highly developed skills that can't be found here. President Trump says it's being abused as a way to find cheap foreign labor. We hear about the benefits—and the risks—of changing the H-1B program.